C

Celltrion Pharm Inc
KOSDAQ:068760

Watchlist Manager
Celltrion Pharm Inc
KOSDAQ:068760
Watchlist
Price: 47 450 KRW -0.94% Market Closed
Market Cap: 2.1T KRW

Intrinsic Value

The intrinsic value of one Celltrion Pharm Inc stock under the Base Case scenario is 22 563.59 KRW. Compared to the current market price of 47 450 KRW, Celltrion Pharm Inc is Overvalued by 52%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
22 563.59 KRW
Overvaluation 52%
Intrinsic Value
Price
C
Worst Case
Base Case
Best Case

Valuation History
Celltrion Pharm Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Celltrion Pharm Inc
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for Celltrion Pharm Inc cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Celltrion Pharm Inc
KOSDAQ:068760
KR
Pharmaceuticals
Market Cap
2.1T KRW
IPO
Feb 3, 2006
KR
Pharmaceuticals
Market Cap
2.1T KRW
IPO
Feb 3, 2006
Price
â‚©false
EPS
â‚©false
Company Overview
Loading...
Business Segments
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Celltrion Pharm Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Celltrion Pharm Inc

Current Assets 391.7B
Cash & Short-Term Investments 63.5B
Receivables 218.5B
Other Current Assets 109.7B
Non-Current Assets 277.8B
Long-Term Investments 230.5m
PP&E 222.7B
Intangibles 39.2B
Other Non-Current Assets 15.7B
Efficiency

Free Cash Flow Analysis
Celltrion Pharm Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Celltrion Pharm Inc

Revenue
477.8B KRW
Cost of Revenue
-355.8B KRW
Gross Profit
122B KRW
Operating Expenses
-84.8B KRW
Operating Income
37.2B KRW
Other Expenses
-15.3B KRW
Net Income
22B KRW
Fundamental Scores

Profitability Score
Profitability Due Diligence

Celltrion Pharm Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Exceptional 1-Year Revenue Growth
Positive 3-Years Revenue Growth
50/100
Profitability
Score

Celltrion Pharm Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Celltrion Pharm Inc's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
60/100
Solvency
Score

Celltrion Pharm Inc's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Celltrion Pharm Inc

There are no price targets for Celltrion Pharm Inc.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Celltrion Pharm Inc is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one Celltrion Pharm Inc stock?

The intrinsic value of one Celltrion Pharm Inc stock under the Base Case scenario is 22 563.59 KRW.

Is Celltrion Pharm Inc stock undervalued or overvalued?

Compared to the current market price of 47 450 KRW, Celltrion Pharm Inc is Overvalued by 52%.

Back to Top